TickerFacts.

Medline Inc. (MDLN): Revenue

Annual figures by period end, from SEC filings.

$28.43B
Year ended 2025-12-31
$29.94B
Trailing 12 months to 2026-06-27
2023-12-31: $23.23B2024-12-31: $25.51B2025-12-31: $28.43B$28.43B
2023-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$28.43B+11.5%2026-02-25, From 2025-01-01
2024-12-31$25.51B+9.8%2026-02-25, From 2024-01-01
2023-12-31$23.23Bn/a2026-02-25, From 2023-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Medline Inc. (MDLN)2025-12-31$28.43B+11.5%
Stryker Corp (SYK)2025-12-31$25.12B+11.2%
3M Co (MMM)2025-12-31$24.95B+1.5%
Becton Dickinson & Co (BDX)2025-09-30$21.84B+8.2%
Boston Scientific Corp (BSX)2025-12-31$20.07B+19.9%
Baxter International Inc (BAX)2025-12-31$11.24B+5.7%
Solventum Corp (SOLV)2025-12-31$8.32B+0.9%
ResMed Inc (RMD)2026-06-30$5.65B+9.9%
Dexcom Inc (DXCM)2025-12-31$4.66B+15.6%

Compare MDLN, SYK, MMM, BDX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗